Travere Therapeutics (TVTX) Deferred Taxes (2014 - 2017)
Travere Therapeutics (TVTX) posted Deferred Taxes of $1.4 million for Q4 2017, up 157.97% on a QoQ basis from -$2.4 million in Q3 2017, and up 111.88% year-over-year from $654129.2 in Q4 2016.
Travere Therapeutics (TVTX) Deferred Taxes (2014 - 2017) Analysis & Trends
Travere Therapeutics' Deferred Taxes history runs 4 years deep, the most recent figure standing at $1.4 million for Q4 2017.
- Quarterly Deferred Taxes rose 111.88% year-over-year to $1.4 million in Q4 2017, while the trailing twelve-month figure through Sep 2018 was $1.4 million (up 107.12% YoY) and the FY2017 annual result came in at -$6.4 million, up 71.65% from the prior year.
- Deferred Taxes was $1.4 million for Q4 2017 at Travere Therapeutics, up from -$2.4 million in the prior quarter.
- Across five years, Deferred Taxes topped out at $28.2 million in Q3 2015 and bottomed at -$40.0 million in Q1 2015.
- A 4-year average of -$3.9 million and a median of -$2.9 million in 2014 frame the typical range for Deferred Taxes.
- Peak annual rise in Deferred Taxes reached 111.88% in 2017, while the deepest fall reached 285.78% in 2017.
- Travere Therapeutics' Deferred Taxes stood at -$2.5 million in 2014, then slumped by 53.74% to -$3.8 million in 2015, then slumped by 208.36% to -$11.7 million in 2016, then surged by 111.88% to $1.4 million in 2017.
- Business Quant data shows TVTX's Deferred Taxes at $1.4 million in Q4 2017, -$2.4 million in Q3 2017, and -$3.4 million in Q2 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -65.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 96.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Travere Therapeutics | 5.21 Bn | 5.21 Bn | 125.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 1.39 Mn |
| Sep 30, 2017 | -2.39 Mn |
| Jun 30, 2017 | -3.36 Mn |
| Mar 31, 2017 | -2.06 Mn |
| Dec 31, 2016 | -11.66 Mn |
| Sep 30, 2016 | 1.29 Mn |
| Jun 30, 2016 | -7.22 Mn |
| Mar 31, 2016 | -5.07 Mn |
| Dec 31, 2015 | -3.78 Mn |
| Sep 30, 2015 | 28.23 Mn |
| Mar 31, 2015 | -40.02 Mn |
| Dec 31, 2014 | -2.46 Mn |